Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life

Kimmie K McLaurin1, Caroline B Hall, E Anne Jackson

  • 1Health Outcomes and Pharmacoeconomics, MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA. mclaurink@medimmune.com

Pediatrics
|January 28, 2009
PubMed

Insights

Late-preterm infants face higher healthcare costs and more health issues than term infants, with these disparities continuing through their first year of life. This highlights a need for better management strategies to reduce infant morbidity and associated expenses.

Area of Science:

  • Neonatal and Developmental Pediatrics
  • Health Services Research
  • Public Health

Background:

  • Late-preterm infants (33-36 weeks gestation) exhibit higher neonatal morbidity and costs than term infants.
  • Limited data exists on whether these health disparities persist beyond the neonatal period.

Purpose of the Study:

  • To investigate the primary causes and financial implications of rehospitalization and overall healthcare utilization for late-preterm and term infants during their first year of life.
  • To compare healthcare costs and rehospitalization rates between late-preterm and term infants.

Main Methods:

  • Retrospective cohort study design.
  • Utilized a large national US database of commercially insured individuals, analyzing data from infants born in 2004 with at least one year of enrollment.
  • Examined all healthcare services and associated costs from birth hospitalization through the first year of life.

Main Results:

  • Evaluated 1683 late-preterm and 33,745 term infants.
  • Late-preterm infants incurred substantially higher birth hospitalization costs ($26,054 vs $2,061) and had longer stays (8.8 vs 2.2 days).
  • First-year healthcare costs were threefold higher for late-preterm infants ($12,247 vs $4,069), with higher rehospitalization rates (15.2% vs 7.9%).

Conclusions:

  • Late-preterm infants experience greater morbidity and significantly higher total healthcare costs compared to term infants, extending throughout the first year of life.
  • Infants with late discharge from birth hospitalization showed the highest rehospitalization rates and costs, suggesting more severe illness.
  • Further research into management strategies and guidelines is crucial to mitigate morbidity and reduce healthcare costs in late-preterm infants.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...